CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study
Authors
Keywords
-
Journal
Drug Metabolism and Personalized Therapy
Volume -, Issue -, Pages -
Publisher
Walter de Gruyter GmbH
Online
2022-12-30
DOI
10.1515/dmpt-2022-0115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of CYP2C9 genetic polymorphism and breviscapine on losartan pharmacokinetics in healthy subjects
- (2021) Hang-Xing Huang et al. XENOBIOTICA
- The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia
- (2021) Liting Wu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis
- (2021) Yoon-A Park et al. Journal of Personalized Medicine
- ADME pharmacogenetics: future outlook for Russia
- (2019) Karin B Mirzaev et al. PHARMACOGENOMICS
- Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
- (2019) Marc A Suchard et al. LANCET
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach
- (2016) Fernando de Andrés et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Genetic variation in the human cytochrome P450 supergene family
- (2015) Kohei Fujikura et al. Pharmacogenetics and Genomics
- URAT1gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemia
- (2015) Hong Sun et al. PHARMACOGENOMICS
- The effect of angiotensin II receptor blockers on hyperuricemia
- (2015) Marissa L. Wolff et al. Therapeutic Advances in Chronic Disease
- European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
- (2014) Gianfranco Parati et al. JOURNAL OF HYPERTENSION
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment
- (2011) Yan Miao et al. HYPERTENSION
- CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases
- (2009) Melanie S. Joy et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Uricosuric Action of Losartan via the Inhibition of Urate Transporter 1 (URAT 1) in Hypertensive Patients
- (2008) T. Hamada et al. AMERICAN JOURNAL OF HYPERTENSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search